Multiwave Revenue and Competitors
Estimated Revenue & Valuation
- Multiwave's estimated annual revenue is currently $1M per year.
- Multiwave's estimated revenue per employee is $61,200
Employee Data
- Multiwave has 17 Employees.
- Multiwave grew their employee count by -6% last year.
Multiwave's People
Name | Title | Email/Phone |
---|
Multiwave Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $34.9M | 548 | 18% | N/A | N/A |
#9 | $50.2M | 394 | -5% | N/A | N/A |
#10 | $13.6M | 243 | -10% | N/A | N/A |
What Is Multiwave?
Multiwave Technologies AG is a deep science technology company headquartered in Geneva, Switzerland. Founded in March 2015, Multiwave identifies market needs across industries and incubates metamaterial technologies to answer these needs with a view to improving living standards. Multiwave Innovation SAS, its wholly owned subsidiary based in France, develops medical devices to improve the quality of imaging in MRI. Assimilate SA, its wholly owned subsidiary based in Switzerland, uses quantitative portfolio analysis and sensors to assist retailers' purchasing decisions and guide their overall marketing strategies to maximise profits. Other technologies in our portfolio include a microwave sensor to detect impurities in liquids as well as a trans-cranial magnetic stimulation device to treat neurological conditions. All our technologies are powered by proprietary software algorithms to accelerate engineering design.
keywords:N/AN/A
Total Funding
17
Number of Employees
$1M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Multiwave News
... Jem Engineering (US), Teraview (UK), Echodyne Inc. (US), Multiwave (Europe), Nanohmics Inc. (US), Metashield LLC (US), and Mediwise (UK).
For their first study, Woolley and Fishbach partnered with the Second City to conduct a multiwave experiment with more than 550 students...
The duration and multiwave nature of the covid-19 pandemic is mediated by several factors: (a) vaccine inequity, expected to last until 2023...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.7M | 18 | -49% | N/A |
#2 | $1.8M | 18 | 0% | N/A |
#3 | $2.9M | 18 | -5% | N/A |
#4 | N/A | 19 | 0% | N/A |
#5 | $15M | 20 | 0% | N/A |